Market Tracker

12/18 6:05pm ET

Incyte Corp (NASDAQ:INCY)

77.05
Data as of Dec 18
 +1.47 / +1.94%
Today’s Change
40.30
Today|||52-Week Range
80.78
+52.18%
Year-to-Date

Today’s Trading

Previous close75.58
Today’s open76.36
Day’s range75.88 - 77.85
Volume1,173,524
Average volume (3 months)1,333,556
Market cap$12.8B
Dividend yield--
Data as of 3:59pm ET, 12/18/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+79.57%
Earnings growth (next 5 years)+39.50%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+4.62+5.30%
MNKMallinckrodt Plc+2.57+2.77%
ENDPEndo International P...+1.72+2.47%
HSPHospira Inc+2.19+3.63%
Data as of 4:03pm ET, 12/18/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts